Marapharm Ventures Inc Stock Deutsche Boerse AG
Equities
CA56575M1086
Healthcare Facilities & Services
Sales 2020 | 2.27 2.12 | Sales 2021 | 3.15 2.95 | Capitalization | 10.06M 9.41M |
---|---|---|---|---|---|
Net income 2020 | -40M -37.41M | Net income 2021 | -8M -7.48M | EV / Sales 2020 | 13,592,488 x |
Net Debt 2020 | 5.3M 4.96M | Net Debt 2021 | 13.31M 12.45M | EV / Sales 2021 | 7,417,546 x |
P/E ratio 2020 |
-0.45
x | P/E ratio 2021 |
-1.08
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 71.26% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Searle
IRO | Public Communications Contact | - | - |
James O’Sullivan
SEC | Corporate Secretary | - | 20-11-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott R. Berman
BRD | Director/Board Member | - | - |
Dylan Rexing
BRD | Director/Board Member | - | 20-10-07 |
1st Jan change | Capi. | |
---|---|---|
+31.96% | 272M | |
+33.74% | 261M | |
+49.42% | 194M | |
+44.98% | 131M | |
-28.57% | 121M | |
+115.91% | 119M | |
0.00% | 86.82M | |
+150.00% | 75.33M | |
+1.20% | 55.24M |